Y
Yue Hang Tang
Researcher at University of Queensland
Publications - 9
Citations - 1029
Yue Hang Tang is an academic researcher from University of Queensland. The author has contributed to research in topics: Alternative splicing & Melanoma. The author has an hindex of 8, co-authored 8 publications receiving 872 citations.
Papers
More filters
Journal ArticleDOI
Functional diversity of the hnRNPs: past, present and perspectives.
TL;DR: The current literature is reviewed to examine hnRNP diversity, and how this impacts upon approaches to the classification of RNA-binding proteins in general is discussed.
Journal ArticleDOI
Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis
Katia Nones,Katia Nones,Nicola Waddell,Nicola Waddell,Nicci Wayte,Ann-Marie Patch,Peter Bailey,Felicity Newell,Oliver Holmes,Oliver Holmes,J. Lynn Fink,Michael C.J. Quinn,Yue Hang Tang,Guy Lampe,Kelly Quek,Kelly A. Loffler,Suzanne Manning,Senel Idrisoglu,David Miller,Qinying Xu,Qinying Xu,Nick Waddell,Peter Wilson,Timothy J. C. Bruxner,Angelika N. Christ,Ivon Harliwong,Craig Nourse,Ehsan Nourbakhsh,Matthew F Anderson,Stephen H. Kazakoff,Conrad Leonard,Conrad Leonard,Scott Wood,Scott Wood,Peter T. Simpson,Peter T. Simpson,Lynne Reid,Lynne Reid,Lutz Krause,Damian J. Hussey,David I. Watson,Reginald V. Lord,Derek J. Nancarrow,Wayne A. Phillips,David C. Gotley,B. Mark Smithers,David C. Whiteman,Nicholas K. Hayward,Peter J. Campbell,John V. Pearson,John V. Pearson,Sean M. Grimmond,Sean M. Grimmond,Andrew Barbour +53 more
TL;DR: Genomic catastrophes have a significant role in the malignant transformation of EAC, and Mutational signature analysis confirms that extreme genomic instability in EAC can be driven by somatic BRCA2 mutations.
Journal ArticleDOI
Protein arginine methyltransferase 6 regulates multiple aspects of gene expression
TL;DR: PRMT6 has a dual role in regulating gene expression and that these two functions can occur independently of each other, and the regulation of alternative splicing by PRMT6 is hormone independent.
Journal ArticleDOI
The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis
Mitchell S. Stark,Mitchell S. Stark,Kerenaftali Klein,Benjamin Weide,Lauren E. Haydu,Annette Pflugfelder,Yue Hang Tang,Jane M. Palmer,David C. Whiteman,Richard A. Scolyer,Graham J. Mann,John F. Thompson,Georgina V. Long,Andrew Barbour,H. Peter Soyer,Claus Garbe,Adrian C. Herington,Pamela M. Pollock,Nicholas K. Hayward +18 more
TL;DR: This panel was found to be superior to currently used serological markers for melanoma progression, recurrence, and survival; and would be ideally suited to monitor tumour progression in patients diagnosed with early metastatic disease to detect relapse following surgical or adjuvant treatment.
Journal ArticleDOI
BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: Implications for melanoma staging and adjuvant therapy
Andrew Barbour,Yue Hang Tang,Nicola Armour,Ken Dutton-Regester,Lutz Krause,Kelly A. Loffler,Duncan Lambie,Bryan Burmeister,Janine Thomas,B. Mark Smithers,Nicholas K. Hayward +10 more
TL;DR: Patients with BRAF mutations experienced rapid progression of metastatic disease with locoregional recurrence rarely seen in isolation, supporting incorporation of BRAF status into melanoma staging and use of BRAf/MEK inhibitors post-TLND.